Veradermics, Inc (MANE) stock
MANENYSEPharmaceutical PreparationsFiscal year ends December 31
$129.66−5.63 (-4.16%)
Close on Nov 13, 2026Market cap $5.42BP/E –Yield –
Veradermics total assets
Total assets on the balance sheet at the end of each period.
Veradermics's total assets was $807.22M at Sep 30, 2026. For fiscal 2025 it was $152.62M, up 174.8% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.62M | +174.8% |
| FY2024 | Dec 31, 2024 | $55.54M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $807.22M | +1353.5% |
| Q2 FY2026 | Jun 30, 2026 | $825.74M | – |
| Q1 FY2026 | Mar 31, 2026 | $397.36M | – |
| Q4 FY2025 | Dec 31, 2025 | $152.62M | – |
| Q4 FY2024 | Dec 31, 2024 | $55.54M | – |
See a number that looks wrong?